You are here

Lexington Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LNB
CSE Index: 
Currency: 

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

You are here

Lexington Biosciences Inc. (LNB)

SEDAR Information

Company Info

Address
1055 West Hastings Street
Suite 1900
Vancouver, BC V6E 2E9
Canada
Phone
(800) 320-2640
Email
info@lexingtonbiosciences.com
Listing date
Tuesday, May 9, 2017
Transfer Agent
AST Trust Company (Canada)

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
3,785,340
Reserved for Issuance: 
322,740

Bulletins

23/04/2019

2019-0417 – Consolidation - Lexington Biosciences, Inc. (LNB)

Le 23 avril/April 2019

Lexington Biosciences, Inc., has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post‐ consolidation share for each ten (10) pre‐consolidation common shares. 

As a result, the outstanding shares of the company will be reduced to approximately 3,785,340 .

The shares will begin trading on a consolidated basis and with a new CUSIP number on April 24, 2019.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

06_19_CSE_Present_eSports_Website_V3

CSE Presents: esports in the Capital Markets

Wednesday, June 19, 2019 -
2:00pm to 6:00pm
06_20_Think_Diversification_Website

Thinking North Presents: Think: Diversification

Thursday, June 20, 2019 -
5:00pm to 8:00pm
06_26_The_Cannabis_Society_1x1_Website

The Cannabis Society 1X1 Executive Conference

Wednesday, June 26, 2019 -
1:00pm to 5:30pm